Log In
    News

    Filament Health (FLHLF) Scheduled to Present at NobleCon18 Investor Conference

    3/15/2022
    Health
    0 min read

    Filament Health CEO Ben Lightburn provides a preview of their upcoming presentation at NobleCon18

    NobleCon18 – Noble Capital Markets 18th Annual Small and Microcap Investor Conference – April 19-21, 2022 – Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel Presentations | High-Profile Keynotes | Educational Sessions | Receptions & Networking Events

    Free Registration Available – More Info


    Research, News, and Advanced Market Data on FLHLF


    About Filament Health

    Filament Health is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines for clinical development. We are paving the way with the first-ever natural psychedelic drug candidates.
    Share
    Related News
    ‌
    Release – Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development
    2/21/2025
    Health

    Release – Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development

    Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received the Certificate of Registration from the United States Patent and Trademark Office (USPTO) on...
    4 min read
    ‌
    Celsius Acquires Alani Nutrition in $1.8 Billion Deal
    2/21/2025
    Food and Services

    Celsius Acquires Alani Nutrition in $1.8 Billion Deal

    Celsius Holdings has announced plans to acquire Alani Nutrition in a landmark $1.8 billion deal, marking a major consolidation in the U.S. energy drink market. The agreement, expected to be...
    3 min read
    ‌
    Release – GDEV Declares One-Time, Nonrecurring Special Cash Dividend of $3.31 Per Share
    2/21/2025
    Media and Entertainment

    Release – GDEV Declares One-Time, Nonrecurring Special Cash Dividend of $3.31 Per Share

    GDEV Inc. (Nasdaq: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”), today announced that its Board of Directors has authorized and approved a one-time, nonrecurring special cash...
    4 min read
    ‌
    Release – Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results
    2/21/2025
    Health

    Release – Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results

    Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that it will...
    3 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In